4//SEC Filing
Hauer Jerome M 4
Accession 0001140361-17-032607
CIK 0001367644other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:32 PM ET
Size
8.7 KB
Accession
0001140361-17-032607
Insider Transaction Report
Form 4
Hauer Jerome M
Director
Transactions
- Award
Common Stock
2017-08-15$25.47/sh+5,153$131,247→ 29,421 total - Sale
Common Stock
2017-08-15$35.83/sh−10,776$386,149→ 18,645 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-08-15−5,153→ 5,152 totalExercise: $25.47Exp: 2022-01-21→ Common Stock (5,153 underlying)
Footnotes (3)
- [F1]Consists of an option granted on January 22, 2015 under the company's stock incentive plan as amended and restated.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.70 to $36.05, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.
Documents
Issuer
Emergent BioSolutions Inc.
CIK 0001367644
Entity typeother
Related Parties
1- filerCIK 0001294935
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:32 PM ET
- Size
- 8.7 KB